STEWARTVILLE, Minn., April 7, 2011 /PRNewswire/ — Rochester
Medical Corporation (NASDAQ:
ROCM) today announced that it has now completed the previously
announced purchase of Laprolan B.V., the former Medical Supplies
Division and wholly owned subsidiary of Fornix BioSciences N.V.
Under the terms of the purchase agreement the purchase is deemed
retroactive to January 1, 2011. For more information
regarding this transaction please refer to the Company’s January
12, 2011 press release. The Company plans to further discuss this
acquisition in its second quarter financial results press release
and conference call which is expected to be held in early May,
2011.
Rochester Medical Corporation develops, manufactures, and
markets latex-free disposable medical catheters and devices for
urological and continence care applications. The Company
markets under its own Rochester Medical® brand and under
existing private label arrangements.
For further information, please contact Anthony J. Conway,
President and Chief Executive Officer or David A. Jonas, Chief
Financial Officer of Rochester Medical Corporation at (507)
533-9600. More information about Rochester Medical is
available on its website at http://www.rocm.com.
‘/>”/>
